Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Charles L LoprinziJohn W Kugler

Abstract

Vasomotor hot flashes are a common problem in menopausal women. Given concerns regarding estrogen and/or combined hormonal therapy, other treatment options are desired. Prior trials have confirmed that progestational agents and newer antidepressants effectively reduce hot flashes. This current trial compared a single intramuscular dose of medroxyprogesterone acetate (MPA), depot preparation, versus daily oral venlafaxine as treatment for hot flashes. Women with bothersome hot flashes were entered onto this trial, were randomly assigned to treatment, and then had a baseline week where hot flash scores were recorded without treatment. They were then treated and observed for 6 weeks; daily diaries were used to measure hot flash frequencies and severities. There were 109 patients per each arm randomly assigned to receive MPA 400 mg intramuscularly for a single dose versus venlafaxine 37.5 mg per day for a week, then 75 mg per day. During the sixth week after random assignment, hot flash scores were reduced by 55% in the venlafaxine arm versus 79% in the MPA arm (P < .0001). In an intention-to-treat analysis, 46% of venlafaxine patients (50 of 109) compared with 74% of the MPA patients (81 of 109) had a decrease in hot flashes by mo...Continue Reading

References

Feb 1, 1968·Annals of Internal Medicine·F M MuggiaG A Hyman
Sep 26, 1980·JAMA : the Journal of the American Medical Association·I SchiffK J Ryan
Jun 15, 1995·The New England Journal of Medicine·G A ColditzF E Speizer
Aug 11, 1994·The New England Journal of Medicine·C L LoprinziN E Klatt
Aug 1, 1996·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·D A RevickiL Howland
Nov 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A SloanN L Vaught
Dec 10, 1998·Journal of Pain and Symptom Management·G FinckJ A Sloan
Feb 5, 2000·JAMA : the Journal of the American Medical Association·C SchairerR Hoover
Jul 5, 2001·British Journal of Cancer·C FocanUNKNOWN Adjuvant Breast Cancer Project Belgium
Dec 4, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A SloanH Windschitl
May 15, 2002·Mayo Clinic Proceedings·Jeff A SloanUNKNOWN Clinical Significance Consensus Meeting Group
Jul 19, 2002·JAMA : the Journal of the American Medical Association·Jacques E RossouwUNKNOWN Writing Group for the Women's Health Initiative Investigators
Jul 19, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G BertelliR Rosso
May 16, 2003·American Journal of Obstetrics and Gynecology·John Eden
Apr 15, 2004·JAMA : the Journal of the American Medical Association·Garnet L AndersonUNKNOWN Women's Health Initiative Steering Committee
Dec 17, 2004·Journal of the National Cancer Institute·Stacey A MissmerSusan E Hankinson
Apr 7, 2005·Journal of the National Cancer Institute·Rowan T Chlebowski, Garnet L Anderson
May 5, 2005·Journal of the National Cancer Institute·Diane PalmieriPatricia S Steeg

❮ Previous
Next ❯

Citations

Jan 29, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Haeseong ParkThomas J Smith
Sep 19, 2007·Breast Cancer Research and Treatment·David Cella, Lesley J Fallowfield
Feb 12, 2009·Breast Cancer Research and Treatment·Debra L Barton, Charles L Loprinzi
Jul 6, 2010·Journal of Cancer Survivorship : Research and Practice·Michelle E MeliskoHope S Rugo
Jan 27, 2007·Current Oncology Reports·H Florence Kim, Michael J Fisch
Dec 17, 2008·Current Oncology Reports·Dawn L HershmanKatherine D Crew
Jan 31, 2012·Asian Journal of Andrology·Jason M JonesCharles L Loprinzi
Nov 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles L LoprinziKelli N Burger
Nov 2, 2011·The Oncologist·Phuong Khanh H MorrowGabriel N Hortobagyi
Aug 8, 2012·International Journal of Women's Health·Elena M Umland, Laura Falconieri
Jul 10, 2009·Women's Health·JoAnn V PinkertonRebecca S Kightlinger
Feb 4, 2009·Menopause : the Journal of the North American Menopause Society·Aditya BardiaCharles Loprinzi
Dec 10, 2013·Expert Review of Anticancer Therapy·Maddalena BarbaPatrizia Vici
Aug 19, 2011·Climacteric : the Journal of the International Menopause Society·D F ArcherM Warren
Aug 7, 2013·Hematology/oncology Clinics of North America·Daniela StanKathryn J Ruddy
Jul 18, 2008·Supportive Cancer Therapy·Aarati RanganathanDebu Tripathy
Apr 3, 2012·Gynécologie, obstétrique & fertilité·G Boutet
Dec 27, 2011·The Journal of Allergy and Clinical Immunology·Teresa CaballeroUNKNOWN C-1-INH Deficiency Working Group
May 24, 2011·Seminars in Oncology·Bassam Estfan
Apr 9, 2011·Gynecologic Oncology·Okechukwu IbeanuAmanda Nickles Fader
Dec 8, 2009·The Lancet Oncology·Charles L Loprinzi, Sherry L Wolf
Jul 18, 2008·Supportive Cancer Therapy·Yuan-Ching ChangWilliam C Dooley
Oct 22, 2008·Seminars in Oncology·Axel GrotheyUNKNOWN North Central Cancer Treatment Group
Apr 4, 2008·Maturitas·David W Sturdee
Jun 26, 2007·Lancet·Vered Stearns
Jun 26, 2007·The Journal of Steroid Biochemistry and Molecular Biology·Lesley Fallowfield
Feb 17, 2007·Seminars in Oncology Nursing·Carrie Tompkins Stricker
Nov 7, 2006·Best Practice & Research. Clinical Obstetrics & Gynaecology·Jennifer Blake
Nov 23, 2006·The Journal of Steroid Biochemistry and Molecular Biology·H A M Verheul, H J Kloosterboer
Oct 28, 2009·Pharmacotherapy·Dana G Carroll, Kristi W Kelley
Jan 29, 2013·CA: a Cancer Journal for Clinicians·William I FisherJanet S Carpenter
Aug 13, 2014·Maturitas·Xiangyan Ruan, Alfred O Mueck
Aug 25, 2006·Clinical Journal of Oncology Nursing·Christine Engstrom
Aug 6, 2016·Mayo Clinic Proceedings·Stephanie S FaubionKathryn J Ruddy
Apr 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Wendall GoodwinKathy S Albain
Dec 6, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles L LoprinziAnthony J Jaslowski
Sep 14, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles L LoprinziRui Qin
Jul 18, 2008·Supportive Cancer Therapy·Aditya BardiaCharles L Loprinzi
Feb 24, 2011·The Annals of Pharmacotherapy·Laura P HayesKristi W Kelley
Jan 24, 2018·Nature Reviews. Clinical Oncology·Ines Vaz-Luis, Ann H Partridge
Sep 7, 2018·Expert Review of Anticancer Therapy·Rosaria Condorelli, Ines Vaz-Luis
Jun 6, 2015·Journal of Menopausal Medicine·Mi Young KimAeli Ryu
Aug 30, 2008·Menopause : the Journal of the North American Menopause Society·Charles L LoprinziSherry Wolf
Mar 24, 2010·Obstetrics and Gynecology·Jan L Shifren, Isaac Schiff
Sep 21, 2010·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Kathleen M KokolusElizabeth A Repasky
Oct 18, 2019·BJOG : an International Journal of Obstetrics and Gynaecology·S IliodromitiM Hickey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Charles L LoprinziN E Klatt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Charles L LoprinziTeresa A Rummans
© 2021 Meta ULC. All rights reserved